p53 as a potential target for treatment of cancer: A perspective on recent advancements in small molecules with structural insights and SAR studies

R Bhatia, B Kumar - European Journal of Medicinal Chemistry, 2023 - Elsevier
Cancer represents one of the world's biggest hazardous diseases. p53 is the uttermost
researched tumour suppressor protein. It is commonly considered the “guardian of the …

A novel alpha‐amylase inhibitor‐based spirooxindole‐pyrrolidine‐clubbed thiochromene‐pyrzaole pharmacophores: Unveiling the [3+ 2] cycloaddition reaction by …

MS Islam, AM Al‐Majid, M Haukka… - Chemical Biology & …, 2023 - Wiley Online Library
A novel spirooxindole‐pyrrolidine clubbed thiochromene and pyrazole motifs were
synthesized by [3+ 2] cycloaddition (32CA) reactions in one step process starting from the …

Novel spirooxindole-triazole derivatives: unveiling [3+ 2] cycloaddition reactivity through molecular electron density theory and investigating their potential cytotoxicity …

I Shawish, S Al Ayoubi, A El-Faham, A Aldalbahi… - Frontiers in …, 2024 - frontiersin.org
A novel analogue of hybrid spirooxindoles was synthesized employing a systematic
multistep synthetic approach. The synthetic protocol was designed to obtain a series of …

Advancements in targeting tumor suppressor genes (p53 and BRCA 1/2) in breast cancer therapy

Chahat, N Nainwal, Y Murti, S Yadav, P Rawat… - Molecular Diversity, 2024 - Springer
Globally, among numerous cancer subtypes, breast cancer (BC) is one of the most prevalent
forms of cancer affecting the female population. A female's family history significantly …

New spiro-indeno[1,2-b]quinoxalines clubbed with benzimidazole scaffold as CDK2 inhibitors for halting non-small cell lung cancer; stereoselective synthesis …

A Barakat, S Alshahrani, AM Al-Majid… - Journal of Enzyme …, 2023 - Taylor & Francis
Despite the crucial role of CDK2 in tumorigenesis, few inhibitors reached clinical trials for
managing lung cancer, the leading cause of cancer death. Herein, we report combinatorial …

Utilizing MEDT analysis of [3+ 2] cycloaddition reaction: x-ray crystallography of spirooxindole linked with thiophene/furan heterocycles and triazole framework

AA Alayyaf, M Ali, MA Alwehaibi, MK Al-Muhanna… - BMC chemistry, 2024 - Springer
Hybridization of spirooxindole with different pharmacophores such as triazole and
heterocycle such as thiophene and furan moiety was achieved by the [3+ 2] cycloaddition …

Rational design, synthesis, separation, and characterization of new spiroxindoles combined with benzimidazole scaffold as an MDM2 inhibitor

S Alshahrani, AM Al-Majid, M Ali, AS Alamary… - Separations, 2023 - mdpi.com
Rational design for a new spiroxindoles, combined with a benzimidazole scaffold to identify
a new murine double minute two (MDM2) inhibitor was synthesized and characterized. The …

Exploring Regio-and Stereoselectivity in [3+ 2] Cycloaddition: Molecular Electron Density Theory Approach for Novel Spirooxindole-Based Benzimidazole with …

S Alshahrani, AM Al-Majid, AS Alamary… - Crystals, 2023 - mdpi.com
A new ethylene derivative was synthesized as a precursor for the [3+ 2] cycloaddition
(32CA) reaction to access a novel spirooxindole embodied with benzimidazole with a …

Activation of p53 signaling and regression of breast and prostate carcinoma cells by spirooxindole-benzimidazole small molecules

A Barakat, S Alshahrani, AM Al-Majid… - Frontiers in …, 2024 - frontiersin.org
This study discusses the synthesis and use of a new library of spirooxindole-benzimidazole
compounds as inhibitors of the signal transducer and activator of p53, a protein involved in …

Synthesis and Characterization of New Spirooxindoles Including Triazole and Benzimidazole Pharmacophores via [3+ 2] Cycloaddition Reaction: An MEDT Study of …

S Alshahrani, AM Al-Majid, AS Alamary, M Ali… - Molecules, 2023 - mdpi.com
A new series of spirooxindoles based on benzimidazole, triazole, and isatin moieties were
synthesized via a [3+ 2] cycloaddition reaction protocol in one step. The single X-ray crystal …